In a 1.3 billion dollar deal, Merck acquired Modifi Bio last fall.
I cover one research team's journey to develop a novel drug for glioblastoma, and a young patient who inspired the team to push forward even when on the verge of running out of funding.
medicine.yale.edu/news-article...